Biohaven Shares Rise About 25% After FDA Accepts Resubmission

The agency set a first-quarter 2027 user-fee goal date and plans to convene an advisory committee, with no meeting date announced.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.